Life Sciences at Goldman Sachs Alternatives
LS
LI

Life Sciences at Goldman Sachs Alternatives

Measured by AhrefsDR74 out of 100, Top 25%. Ahrefs DR. Open the scores section.Ahrefs DR: 74/100. Top 25%. Measured by Ahrefs. Median 44.

venture_capital2 portfolioUnited States

About

Life Sciences at Goldman Sachs Alternatives is the life sciences investment arm of Goldman Sachs Asset Management, investing in innovative biopharmaceutical and medical technology companies through its alternatives platform. The group provides growth and late-stage capital to companies developing breakthrough therapies and healthcare technologies.

Key facts

Website
gsam.com
Type
venture_capital
Headquarters
United States
Portfolio companies
2
Cheque size
$137M to $137M
Sector focus
Life Sciences
Biotech
Pharmaceuticals
Medical Technology

Recent investments

Recent funding rounds Life Sciences at Goldman Sachs Alternatives took part in
DateCompanyRoundAmount
8 Apr 2026Sidewinder TherapeuticsSeries B$137M
9 Jan 2026AirNexis TherapeuticsSeries A$200M

Test your Ahrefs DR

The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.

Write the first review

Frequently asked

What companies has Life Sciences at Goldman Sachs Alternatives invested in?

Life Sciences at Goldman Sachs Alternatives has invested in Sidewinder Therapeutics, AirNexis Therapeutics.

SEC filings, insider activity, nonprofit links and pay benchmarks for Life Sciences at Goldman Sachs Alternatives: